EUVIMEDEUVIMED entdecken
Crossref

Using Off‐Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy

Sunita Rehal iD, Nicky Best iD, Sarah Watts, Thomas Drury iD

Pharmaceutical Statistics · 2026

DOI: 10.1002/pst.70070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2026. Verfasst von Sunita Rehal und 3 weiteren Autor:innen. Beteiligte Einrichtung: GlaxoSmithKline, London, UK. Hauptthemen laut MEDLINE: Models, Statistical, Clinical Trials, Phase III as Topic, Research Design. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The estimand framework proposes different strategies to address intercurrent events. The treatment policy strategy seems to be the most favoured as it is closely aligned with the pre‐addendum intention‐to‐treat principle. All data for all patients should ideally be collected; however, in reality patients may withdraw from a study leading to missing data. This needs to be dealt with as part of the estimation. A common intercurrent event we focus on is treatment discontinuation. Several areas of research have been conducted exploring models to estimate the estimand when intercurrent events are handled using a treatment policy strategy; however, the research is limited for binary endpoints. We explore different retrieved dropout models, where post‐intercurrent event, the observed data can be used to multiply impute the missing post‐intercurrent event data. We compare our proposed models to a simple imputation model that makes no distinction between the pre‐ and post‐intercurrent event data, and assess varying statistical properties through a simulation study. We then provide an example of how retrieved dropout models were used in practice for Phase 3 clinical trials in rheumatoid arthritis. From the models explored, we conclude that a simple retrieved dropout model including an indicator for whether or not the intercurrent event occurred is the most pragmatic choice. However, at least 50% of observed post‐intercurrent event data is required for these models to work well. Therefore, the suitability of implementing this model in practice will depend on the amount of observed post‐intercurrent event data available and missing data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Models, StatisticalClinical Trials, Phase III as TopicResearch DesignHumansData Interpretation, StatisticalPatient DropoutsArthritis, RheumatoidComputer SimulationTreatment Outcome

Stichwörter der Autor:innen

binary endpointestimandsmissing datamultiple imputationtreatment policy

Autor:innen und Institutionen

  • GlaxoSmithKline, London, UK.

ORCID-Profile: Sunita Rehal, Nicky Best, Thomas Drury

Zitieren

APA

Rehal, S., Best, N., Watts, S., & Drury, T. (2026). Using Off‐Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy. Pharmaceutical Statistics. https://doi.org/10.1002/pst.70070

Vancouver

Rehal S, Best N, Watts S, Drury T. Using Off‐Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy. Pharmaceutical Statistics. 2026. doi:10.1002/pst.70070

BibTeX
@article{Rehal2026,
  author = {Rehal, Sunita and Best, Nicky and Watts, Sarah and Drury, Thomas},
  title = {Using Off‐Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy},
  journal = {Pharmaceutical Statistics},
  year = {2026},
  doi = {10.1002/pst.70070}
}
Kostenlos starten →